Zdrowie i gospodarka · 23/07/2024
FDA Releases Draft Guidance on Postapproval Manufacturing Changes for Biosimilar and Interchangeable Biosimilar Products
The FDA has published a draft guidance document addressing postapproval manufacturing changes for biosimilar and interchangeable biosimilar products, providing answers to frequently asked questions from applicants and other stakeholders.